Factors associated with colposcopy-Histopathology confirmed cervical intraepithelial neoplasia among HIV-infected women from Rio de Janeiro, Brazil

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  de Andrade, Angela Cristina Vasconcelos ^a   Luz, Paula Mendes ^a   Velasque, Luciane ^a,b   Veloso, Valdiléa Gonçalves ^a   Moreira, Ronaldo I ^a   Russomano, Fabio ^c   Chicarino Coelho, Janice ^a   Pires, Elaine ^a   Levi, José Eduardo ^d   Grinsztejn, Beatriz ^a   Friedman, Ruth Khalili ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BRAZIL; CANCER RISK; CANCER STAGING; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; PROSPECTIVE STUDY; SCREENING TEST; TOBACCO; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; BEHAVIOR; DEMOGRAPHY; PATHOLOGY; REPRODUCIBILITY; VIROLOGY;

HUMAN PAPILLOMAVIRUS; NICOTIANA TABACUM;

ADULT; BEHAVIOR; BRAZIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; PREVALENCE; REPRODUCIBILITY OF RESULTS;

EID: 79953299215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018297     Document Type: Article

References (33)

1. UNAIDS (2010) AIDS epidemic update 2009. Joint United Nations Programme on HIV/AIDS Access date November 06 2010.
2. Palefsky JM, (2003) Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 15: 382-388.
3. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, et al. (2005) Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 97: 577-586.
4. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
5. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, et al. (2005) Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97: 425-432.
6. Franceschi S, Jaffe H, (2007) Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 45: 510-513.
7. Arrossi S, Sankaranarayanan R, Parkin DM, (2003) Incidence and mortality of cervical cancer in Latin America. Salud Publica Mex 45 (Suppl 3): S306-314.
8. Orem J, Otieno MW, Remick SC, (2004) AIDS-associated cancer in developing nations. Curr Opin Oncol 16: 468-476.
9. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF, (2004) Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 109: 418-424.
10. INCA (2009) Estimativa 2010: Incidência do câncer no Brasil. Rio de Janeiro, Brasil Instituto Nacional do Câncer. Ministério da Sáude.
11. Heard I, Tassie JM, Kazatchkine MD, Orth G, (2002) Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. Aids 16: 1799-1802.
12. Solomon D, Schiffman M, Tarone R, (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93: 293-299.
13. MS, (2006) Manual de Controle das Doenças Sexualmente Transmissíveis. Secretaria de Vigilância em Saúde. Programa Nacional de DST e AIDS. Brasil Ministério da Saúde.
14. Walker P, Dexeus S, De Palo G, Barrasso R, Campion M, et al. (2003) International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol 101: 175-177.
15. INCA (2006) Nomenclatura brasileira para laudos cervicais e condutas preconizadas: recomendações para profissionais de saúde. Rio de Janeiro, Brasil Instituto Nacional do Cancer. Ministério da Saude.
16. Prendiville W, Cullimore J, Norman S, (1989) Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intraepithelial neoplasia. Br J Obstet Gynaecol 96: 1054-1060.
17. Richart RM, (1990) A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 75: 131-133.
18. Barros AJ, Hirakata VN, (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3: 21.
19. Behrens T, Taeger D, Wellmann J, Keil U, (2004) Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med 43: 505-509.
20. Petersen MR, Deddens JA, (2008) A comparison of two methods for estimating prevalence ratios. BMC Med Res Methodol 8: 9.
21. Dexeus S, Cararach M, Dexeus D, (2002) The role of colposcopy in modern gynecology. Eur J Gynaecol Oncol 23: 269-277.
22. Anastos K, Hoover DR, Burk RD, Cajigas A, Shi Q, et al. (2010) Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One 5: e13525.
23. Bollen LJ, Chuachoowong R, Kilmarx PH, Mock PA, Culnane M, et al. (2006) Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization. Sex Transm Dis 33: 259-264.
24. Sahasrabuddhe VV, Bhosale RA, Joshi SN, Kavatkar AN, Nagwanshi CA, et al. (2010) Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India. PLoS One 5: e8634.
25. Zimmermmann JB, Melo VH, Castro LPF, Alves MJM, Zimmermmann SJ, et al. (2006) Association between CD4+ T-cell count and intraepithelial cervical neoplasia diagnosed by histopathology in HIV-infected women. Revista Brasileira de Ginecologia e Obstetricia 28: 345-351.
26. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, et al. (2006) Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 103: 1017-1022.
27. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, et al. (1999) Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 21: 33-41.
28. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, et al. (2002) HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359: 108-113.
29. Jamieson DJ, Paramsothy P, Cu-Uvin S, Duerr A, (2006) Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus. Obstet Gynecol 107: 1023-1028.
30. Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, et al. (2004) Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 190: 1241-1248.
31. Campos DP, Ribeiro SR, Grinsztejn B, Veloso VG, Valente JG, et al. (2005) Survival of AIDS patients using two case definitions, Rio de Janeiro, Brazil, 1986-2003. Aids 19 (Suppl 4): S22-26.
32. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, et al. (2006) Trends in cancer risk among people with AIDS in the United States 1980-2002. Aids 20: 1645-1654.
33. Franceschi S, Dal Maso L, Pezzotti P, Polesel J, Braga C, et al. (2003) Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr 34: 84-90.